Advances in gout some answers, more questions.docVIP

Singh Arthritis Research Therapy 2010,12:136 /content/12/5/136 EDITORIAL Advances in gout: some answers, more questions Jasvinder A Singh* 1-4 See related research by Becker et al., /content/12/2/R63 based on the solubility of urate at 37°C (6.8 mg/dl), levels Abstract below which have been associated with lower risk of gout ? ares and tophi [2-4]. A target serum urate was achieved in signi? cantly more patients in the febuxostat 80 mg group (67%) compared to the 40 mg group (45%) and the allopurinol group (42%; 300 mg daily or 200 mg daily in moderate renal impairment); the 40